HER2阳性实体瘤的临床试验
总计5921个结果
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)终止
-
Kite, A Gilead Company终止
-
Eikon TherapeuticsSeven and Eight Biopharmaceuticals Inc完全的
-
Debiopharm International SA完全的
-
Samsung Medical Center完全的
-
AnHeart Therapeutics Inc.完全的
-
Institut Claudius Regaud完全的
-
Merck Sharp & Dohme LLCAriad Pharmaceuticals完全的
-
Daiichi Sankyo招聘中
-
National Health Research Institutes, TaiwanNational Cheng-Kung University Hospital招聘中
-
Elpiscience Biopharma, Ltd.Shanghai Junshi Bioscience Co., Ltd.招聘中
-
Zhuhai Yufan Biotechnologies Co., Ltd招聘中
-
Zhuhai Yufan Biotechnologies Co., Ltd招聘中
-
Seoul National University Bundang HospitalRoche Pharma AG; Korean Cancer Study Group招聘中
-
University Hospital, MontpellierSoroptimist association of Monaco招聘中
-
Ankyra Therapeutics, Inc招聘中
-
University of ArizonaPfizer完全的
-
Syndax Pharmaceuticals完全的
-
AstraZeneca完全的Advanced Solid Metastatic Tumor英国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
University of ChicagoNational Cancer Institute (NCI)完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)撤销未明确的儿童实体瘤,具体方案 | 未明确的成人实体瘤,特定方案
-
Ruth O'ReganUniversity of Rochester; Puma Biotechnology, Inc.招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Genentech, Inc.招聘中晚期实体瘤 | 转移性实体瘤加拿大, 大韩民国, 美国, 巴西, 澳大利亚, 阿根廷, 西班牙, 新西兰, 波兰
-
The First Affiliated Hospital of Xiamen University招聘中
-
Nectin Therapeutics LtdMerck Sharp & Dohme LLC招聘中癌症 | 转移癌 | 晚期实体瘤 | 肿瘤,实体 | 局部晚期实体瘤美国, 以色列
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.完全的
-
Bristol-Myers Squibb完全的